Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 434

Sort by

Sort Order Select

Journal Articles

Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Juan José Rodríguez-Sevilla, Fernando Jesús Reyes-Zurita, Rosa Collado, Anna Puiggros, Elena Cornejo-Calvo, Paloma García-Martín, Rob Ter Horst, Yolanda Benavente, Andrés Jerez, Stefano Landi, Blanca Espinet, Rossana Maffei, Miguel Ángel López-Nevot, Silvia Ramos-Campoy, Carmen González-Olmedo, Tzu-Hua Chen-Liang, Víctor Moreno, Fatin Jannus, Rafael Marcos-Gragera, María Carretero-Fernández, Belém Sampaio-Marques, Irene Gámez, María García-Álvarez, Nicola J. Camp, Trinidad Dierssen-Sotos, Joanna Kamaso, Eva María Pérez, Aaron D. Norman, Mario Luppi, Yang Li, Miguel Alcoceba, Daniele Campa, Silvia de San José, Roberto Marasca, Paula Ludovico, Alyssa Clay-Gilmour, Federico Canzian, Marian Ibañez, Mihai G. Netea, James McKay, Delphine Casabonne, Sonja I. Berndt, Susan L. Slager, Juan Sainz

Blood Adv (2025) 9 (23): 6076–6089.

https://doi.org/10.1182/bloodadvances.2025017345

Published: 2025

Includes: Supplemental data

Journal Articles

Biological parenthood rates among men with sickle cell disease

Anyssa N. Young, Sarah R. Hayford, Sapuni S. Chandrasena, Sara Conroy, Tanvi P. Karkare, Barbara L. Kroner, Allison King, Robert M. Cronin, Luca Badolato, Leena Nahata, Susan E. Creary

Blood Adv (2025) 9 (23): 6059–6062.

https://doi.org/10.1182/bloodadvances.2025017458

Published: 2025

Journal Articles

Hairy Cell Leukemia: a chronic B-lymphoma with unique clinicopathological features and unresolved molecular mechanisms

Ge Zhang, Jiancheng Hu

Blood Adv bloodadvances.2025017165.

https://doi.org/10.1182/bloodadvances.2025017165

Published: 2025

Journal Articles

National landscape of pediatric and adult inpatient sickle cell disease care

Ashley Jenkins, Spoorthy Vangala, Matthew McIntosh, Robert LeGros, Sophie Lanzkron, Kevin Fiscella

Blood Adv bloodadvances.2025018089.

https://doi.org/10.1182/bloodadvances.2025018089

Published: 2025

Includes: Supplemental data

Journal Articles

An AI model classifies risks of early relapse post–CAR T-cell therapy in a multicenter real-world population with DLBCL

Michelle Wang, Krishna V. Komanduri, Debajyoti Datta, Ayan Patel, Barbee Whitaker, Artur Belov, Benjamin Rubin, Rohit Vashist, Rosa Rodriguez-Monguio, Pelin Cinar, Steven Anderson, Atul J. Butte

Blood Adv (2025) 9 (22): 5837–5852.

https://doi.org/10.1182/bloodadvances.2025016375

Published: 2025

Includes: Supplemental data

Journal Articles

Neighborhood socioeconomic status and overall survival among children with acute lymphoblastic leukemia

Anna L. Hoppmann, Deborah M. Hurley, Stuart Cramer, Monique J. Brown, Rahul Ghosal, Anthony J. Alberg, Smita Bhatia

Blood Adv (2025) 9 (22): 5861–5869.

https://doi.org/10.1182/bloodadvances.2025017044

Published: 2025

Includes: Supplemental data

Journal Articles

Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report

Blood Adv (2025) 9 (22): 5738–5751.

https://doi.org/10.1182/bloodadvances.2025016670

Published: 2025

Includes: Supplemental data

Journal Articles

Beyond the CAR-T horizon in mantle cell lymphoma

Thomas E. Lew, John F. Seymour

Blood Adv (2025) 9 (21): 5651–5653.

https://doi.org/10.1182/bloodadvances.2025017583

Published: 2025

Journal Articles

Treatment and outcomes of progression of disease post–CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

Blood Adv (2025) 9 (21): 5654–5662.

https://doi.org/10.1182/bloodadvances.2025016315

Published: 2025

Includes: Supplemental data

Journal Articles

KDIGO-defined kidney dysfunction predicts long-term outcomes in a multicenter cohort of adults with sickle cell disease

Xu Zhang, Michael R. DeBaun, Kristin Wuichet, Rima Zahr, Zalaya Ivy, Mitchell J. Weiss, Alex G. Bick, Victor R. Gordeuk, Santosh L. Saraf

Blood Adv (2025) 9 (21): 5610–5615.

https://doi.org/10.1182/bloodadvances.2025017204

Published: 2025

Includes: Supplemental data

Journal Articles

Intranasal Fentanyl and Impact of an Emergency Department Pain Protocol for Sickle Cell Disease on Hospitalization Rates

Olufuke Y Martin, Sean M Thompson, Matthew Hays, Seethal A Jacob

Blood Adv bloodadvances.2025016309.

https://doi.org/10.1182/bloodadvances.2025016309

Published: 2025

Includes: Supplemental data

Journal Articles

Immunoglobulin use, survival, and infection outcomes in patients with chronic lymphocytic leukemia

Sara Carrillo de Albornoz, Xin Zhang, Rainier Arnolda, Aleece MacPhail, Adam Irving, Alisa M. Higgins, Erica M. Wood, Zoe K. McQuilten, Dennis Petrie

Blood Adv (2025) 9 (20): 5367–5377.

https://doi.org/10.1182/bloodadvances.2025015867

Published: 2025

Includes: Supplemental data

Journal Articles

Updating clinical guidelines with limited evidence: case study of ASH/ISTH pediatric VTE treatment guidelines

Ali Choaib, Aseel AlKhader, Muayad Azzam, Hassan Kawtharany, Marisol Betensky, Leslie Raffini, Rachel Bercovitz, Sara K. Vesely, Paul Monagle, Reem A. Mustafa

Blood Adv (2025) 9 (20): 5347–5349.

https://doi.org/10.1182/bloodadvances.2025017398

Published: 2025

Journal Articles

Assessment of classical hematologists and classical hematology fellowship programs at NCI-designated cancer centers

Lewis T. Go, Lucas T. Go, Madugodaralalage D. S. K. Gunaratne, Alexandra P. Wolanskyj-Spinner, Aneel A. Ashrani, Michelle A. Elliott, Richard L. Godby, Christopher C. Hook, Leslie J. Padrnos, Rajiv K. Pruthi, Candido E. Rivera, Rachelle L. Rouse, Surbhi Shah, Marwan E. Shaikh, Mustaqeem A. Siddiqui, Meera Sridharan, Ewa M. Wysokinska, Ronald S. Go, Jithma P. Abeykoon

Blood Adv (2025) 9 (20): 5343–5346.

https://doi.org/10.1182/bloodadvances.2025016644

Published: 2025

Journal Articles

Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML

Abdulrahman Alhajahjeh, Kishan K. Patel, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez, Stuart Seropian, Lohith Gowda, Scott F. Huntington, Maximilian Stahl, Amer M. Zeidan, George Goshua, Jan Philipp Bewersdorf

Blood Adv (2025) 9 (20): 5234–5246.

https://doi.org/10.1182/bloodadvances.2025016532

Published: 2025

Includes: Supplemental data

Journal Articles

Comparative outcomes of HSCT with posttransplant cyclophosphamide in older adults: the impact of donor type

Yosra M. Aljawai, Jeremy Ramdial, Portia Smallbone, George Chen, Partow Kebriaei, Oren Pasvolsky, Uday Popat, Betul Oran, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta

Blood Adv (2025) 9 (20): 5201–5206.

https://doi.org/10.1182/bloodadvances.2025016592

Published: 2025

Includes: Supplemental data

Journal Articles

Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fractures

Michelle H Lee, Yating Wang, Angel M. Cronin, Angela C Tramontano, Lachelle D. Weeks, Gabriela S Hobbs

Blood Adv bloodadvances.2025017168.

https://doi.org/10.1182/bloodadvances.2025017168

Published: 2025

Includes: Supplemental data

Journal Articles

Moving the needle on chronic GVHD of the lung

Julie R. Boiko, Kenneth R. Cooke

Blood Adv (2025) 9 (19): 5038–5039.

https://doi.org/10.1182/bloodadvances.2025017297

Published: 2025

Journal Articles

Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease

Husham Sharifi, Carson Tyler Moss, Zayan Musa, Alexander Bell, Christian O’Donnell, Carlos Hernandez Borges, Efthymia Iliana Matthaiou, Laura Johnston, Craig J. Galban, Ajay Sheshadri, Gregory Yanik, Guang-Shing Cheng, Joe L. Hsu

Blood Adv (2025) 9 (19): 5024–5037.

https://doi.org/10.1182/bloodadvances.2025016122

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation

Alison Grazioli, Michael Plazak, Kate Willsey, Joseph Rabin, Raymond P. Rector, Leonid Belyayev, Allison S. Lankford, Thomas M. Scalea, Aakash Shah, Bradley S. Taylor, Mark T. Gladwin

Blood Adv (2025) 9 (19): 4881–4890.

https://doi.org/10.1182/bloodadvances.2025016368

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

Biological parenthood rates among men with sickle cell disease

Hairy Cell Leukemia: a chronic B-lymphoma with unique clinicopathological features and unresolved molecular mechanisms

National landscape of pediatric and adult inpatient sickle cell disease care

An AI model classifies risks of early relapse post–CAR T-cell therapy in a multicenter real-world population with DLBCL

Neighborhood socioeconomic status and overall survival among children with acute lymphoblastic leukemia

Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report

Beyond the CAR-T horizon in mantle cell lymphoma

Treatment and outcomes of progression of disease post–CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

KDIGO-defined kidney dysfunction predicts long-term outcomes in a multicenter cohort of adults with sickle cell disease

Intranasal Fentanyl and Impact of an Emergency Department Pain Protocol for Sickle Cell Disease on Hospitalization Rates

Immunoglobulin use, survival, and infection outcomes in patients with chronic lymphocytic leukemia

Updating clinical guidelines with limited evidence: case study of ASH/ISTH pediatric VTE treatment guidelines

Assessment of classical hematologists and classical hematology fellowship programs at NCI-designated cancer centers

Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML

Comparative outcomes of HSCT with posttransplant cyclophosphamide in older adults: the impact of donor type

Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fractures

Moving the needle on chronic GVHD of the lung

Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease

Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only